Intranasal Corticosteroids Market Report 2026

Intranasal Corticosteroids Market Overview

• Intranasal Corticosteroids market size has reached to $6.78 billion in 2025 • Expected to grow to $9.74 billion in 2030 at a compound annual growth rate (CAGR) of 7.4% • Growth Driver: The Rise In allergic rhinitis Is Driving The Growth Of The Market Due To Increasing Environmental Pollution And Allergen Exposure • Market Trend: Innovative Nasal Spray Technology Enhances Targeted Treatment For Chronic Sinus Conditions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Intranasal Corticosteroids Market?

Intranasal corticosteroids refer to anti-inflammatory medications delivered through the nose to treat conditions such as allergic rhinitis and nasal polyps. They help reduce swelling, congestion, and mucus production in the nasal passages, improving breathing and relieving allergy symptoms. The main drug types of intranasal corticosteroids are prescribed drugs and over-the-counter drugs. Prescribed intranasal corticosteroids are doctor-authorized medications used for moderate to severe allergic rhinitis or chronic nasal inflammation, often preferred for long-term or specialized treatment under medical supervision. The various applications involved are allergic rhinitis, nasal polyps, sinusitis, and other related conditions. They are distributed through multiple channels, including hospital pharmacies, retail pharmacies, online pharmacies, and others, and are used by several end users, such as hospitals, clinics, homecare settings, and healthcare providers.

What Is The Intranasal Corticosteroids Market Growth Forecast?

The intranasal corticosteroids market size is expected to see strong growth in the next few years. It will grow to $9.74 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing healthcare awareness, growth of retail and online pharmacies, rising incidence of chronic rhinitis and nasal polyps, adoption of combination therapies, development of patient-friendly spray devices. Major trends in the forecast period include rising prevalence of allergic rhinitis and nasal disorders, increasing adoption of prescription intranasal corticosteroids, growth in over-the-counter intranasal corticosteroid use, expansion of hospital and homecare distribution channels, focus on patient-centric treatment and ease of administration.

Global Intranasal Corticosteroids Market Segmentation

1) By Drug Types: Prescribed Drugs, Over-The-Counter Drugs 2) By Application: Allergic Rhinitis, Nasal Polyps, Sinusitis, Other Applications 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channel 4) By End User: Hospitals, Clinics, Homecare, Healthcare Providers Subsegments: 1) By Prescribed Drugs: Fluticasone Propionate, Mometasone Furoate, Budesonide, Beclomethasone Dipropionate, Ciclesonide 2) By Over-The-Counter Drugs: Triamcinolone Acetonide, Fluticasone Furoate, Budesonide Over-The-Counter Drugs

What Is The Driver Of The Intranasal Corticosteroids Market?

The increasing prevalence of allergic rhinitis is expected to propel the growth of the intranasal corticosteroids market going forward. Allergic rhinitis is an allergic reaction that causes inflammation of the nasal passages, typically triggered by airborne allergens such as pollen, dust mites, mold, or pet dander. The increasing prevalence of allergic rhinitis is primarily due to rising environmental pollution, which exposes individuals to airborne allergens and irritants that trigger allergic responses in the nasal passages. Intranasal corticosteroids help manage allergic rhinitis by reducing inflammation in the nasal passages, which reduces symptoms such as sneezing, congestion, and a runny nose. For instance, in October 2023, according to the National Library of Medicine, a US-based biomedical library, allergic rhinitis affects more than 400 million people worldwide, with prevalence rates estimated at 10% to 30% among adults and over 40% in children. Therefore, the growing prevalence of allergic rhinitis is driving the intranasal corticosteroid industry.

Key Players In The Global Intranasal Corticosteroids Market

Major companies operating in the intranasal corticosteroids market are GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Haleon plc, Intas Pharmaceuticals Limited, Organon Pharma (UK) Limited, Sun Pharmaceutical Industries Ltd., Apotex Inc., Perrigo Company plc, Aurobindo Pharma Limited, Cipla Ltd., Hikma Pharmaceuticals plc, Zydus Lifesciences Ltd., Glenmark Pharmaceuticals Limited, OptiNose US Inc., Taro Pharmaceutical Industries Ltd., Maya Biotech Private Limited, AdvaCare Pharma USA, Lupin Ltd., Xenone Healthcare Private Limited.

Global Intranasal Corticosteroids Market Trends and Insights

Major companies operating in the intranasal corticosteroids market are focusing on developing innovative formulations, such as nasal sprays, to enhance targeted delivery and improve patient compliance. Nasal sprays are liquid medications delivered directly into the nose through a spray nozzle to treat conditions such as allergies, congestion, or inflammation. They allow fast drug absorption through the nasal mucosa, offering quick relief with minimal systemic effects. For instance, in March 2024, OptiNose Inc., a US-based pharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for XHANCE, the first and only treatment indicated explicitly for adults suffering from chronic rhinosinusitis (CRS) without nasal polyps. This nasal spray utilizes a unique exhalation delivery system that enables the medication to reach deep into the nasal cavity, effectively treating CRS with or without nasal polyps in adults. Each spray delivers 93 mcg of fluticasone propionate, and the device operates by having the user blow into a mouthpiece while simultaneously releasing the spray into the nostril, ensuring precise delivery and enhanced symptom relief.

What Are Latest Mergers And Acquisitions In The Intranasal Corticosteroids Market?

In April 2023, SK Capital Partners LP, a US-based investment firm, acquired Apotex for an undisclosed amount. With this acquisition, SK Capital Partners aims to strengthen apotex’s global position in affordable pharmaceuticals by investing in its growth, operational efficiency, and product innovation. Apotex Inc. is a Canada-based company that manufactures intranasal corticosteroid sprays.

Regional Insights

North America was the largest region in the intranasal corticosteroids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Intranasal Corticosteroids Market?

The intranasal corticosteroids market consists of sales of fluticasone propionate nasal spray, mometasone furoate nasal spray, budesonide nasal spray, beclomethasone dipropionate nasal spray, and triamcinolone acetonide nasal spray. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Intranasal Corticosteroids Market Report 2026?

The intranasal corticosteroids market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the intranasal corticosteroids industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.